It is demonstrated that KRAS is a central node in regulating growth factor-induced cell migration, and that KRAS inhibition plays a broader role than MAPK-mediated cell proliferation and survival.
Yang Yang, Ting-Yu Liu, Charles Y. Cho et al.· Oncogene· 0 citations
Radioligand therapy (RLT) delivers therapeutic radionuclides to tumor-associated targets through specific targeting ligands and has demonstrated substantial clinical value in malignancies such as prostate cancer and neuroendocrine tumors. Beyond its direct induction of radiation-mediated tumor cell damage, RLT has attr...
Sen Wang, Shou-Jun Tang, Sheng-Jie Tang et al.· Frontiers in Pharmacology· 0 citations
This review systematically dissects how dysregulated m6A methylation fuels malignant transformation and progression by reinforcing core oncogenic hallmarks, sustained proliferation, metastasis, metabolic rewiring, and resistance to programmed cell death.
Sheng-Jie Tang, Rangping Xie, Jiang Fu et al.· Molecular Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.